CF Lung Infection Therapy AR-501 Granted FDA Orphan Drug Status
https://cysticfibrosisnewstoday.com/2019/07/01/ar-501-receives-orphan-drug-status-as-treatment-for-lung-infections/CF Patients Enrolling in Trial of Inhaled Treatment for P. aeruginosa Infections
https://cysticfibrosisnewstoday.com/2020/04/13/phase-1-2-trial-ar-501-inhaled-lung-infections-treatment-enrolling-cf-patients-despite-covid-19/